Ibogaine Scientific Research with Thomas Kingsley Brown, Ph.D

Ibogaine Scientific Research with Thomas Kingsley Brown, Ph.D

With a master's degree in chemistry and a Ph.D. in anthropology, Dr. Thomas Kingsley Brown takes a comprehensive approach to study topics of altered states of consciousness, religious conversion, and the uses of ibogaine in the treatment of opioid addiction. He joins us today to discuss the current research into ibogaine.

Ibogaine is not one of the most well-known psychoactive compounds. Dr. Brown explains what this plant medicine is and what it is derived from. Ibogaine is most often derived from the root bark of the iboga shrub from west-central Africa. It was used by certain African populations in a ceremonial context for centuries.

Dr. Brown delves into some of ibogaine's more recent history as a treatment for opioid addiction. Its anti-addiction effects were anecdotally first discovered by accident in the 1960s by Howard Lotsof. After an experience with ibogaine, Lotsof found that he no longer desired heroin. This kicked off a career researching the anti-addiction effects of this compound.

Dr. Brown shares what his research has gleaned concerning ibogaine's mechanism of action. The full mechanism is still not entirely clear. However, he has found that it acts in two ways. First, there is a biochemical action in the brain and body. There is also a powerful psychoactive effect. These two effects seem to work in tandem to eliminate opioid desire and withdrawal symptoms. Research participants have reported several intriguing observations besides a drop in drug use, particularly an improvement in social wellbeing.

In this episode:
  • The natural and artificial sources of ibogaine
  • How ibogaine became associated with opioid addiction recovery
  • What is known about ibogaine's mechanism of action
  • Common experiences of people who have undergone ibogaine therapy
  • Possible effects of ibogaine to promote neural health
  • Thoughts on the efficacy of using medicines with tribal origins in a clinical setting

Quotes:

"It seems that this would facilitate rewiring of the brain. You could look at this as being a potential mechanism for creating new pathways where you're not automatically going into your addictive behavior." [12:46]

"Even if you're not using it to treat addiction, it will force you to confront things you've been avoiding." [17:05]

"As an anthropologist, it seems to me that the more we can set our intentions going in, really being careful about the setting, then the better we'll do with these psychedelic therapies." [29:32]

Links:

MAPS

Check out the full episode post

Keep up with everything Plant Medicine related here

Porangui

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(209)

Why Psychedelics Don't Always Change Us with Nigel Denning, MA, MPsych

Why Psychedelics Don't Always Change Us with Nigel Denning, MA, MPsych

In this episode of the Psychedelic Medicine Podcast, Nigel Denning, MA, MPsych, joins to discuss the reasons profound psychedelic experiences don't always lead to lasting change. Nigel is a Counsellin...

9 Sep 35min

Who Is a Good Candidate for Ibogaine? with Fernando Rivas, MD

Who Is a Good Candidate for Ibogaine? with Fernando Rivas, MD

In this episode of the Psychedelic Medicine Podcast, Fernando Rivas, MD, joins to unpack the safety and screening considerations for ibogaine therapy. Dr. Rivas is an emergency physician with over 15 ...

27 Aug 39min

Encore Episode: Psychedelics and Breathwork with Kyle Buller

Encore Episode: Psychedelics and Breathwork with Kyle Buller

This encore episode of the Psychdelic Medicine Podcast features a conversation with Kyle Buller on psychedelics and breathwork. Kyle is co-founder and host of the Psychedelics Today podcast and he has...

13 Aug 43min

Psychedelics and Psychosis with Alexander Lebedev, MD, PhD

Psychedelics and Psychosis with Alexander Lebedev, MD, PhD

In this episode of the Psychedelic Medicine Podcast, Alexander Lebedev, MD, PhD joins to discuss psychedelic medicine and psychosis. Dr. Lebedev is a physician-scientist, medical AI engineer, and entr...

30 Juli 46min

Psychedelics and GLP-1s with Arsalan Azam, MD

Psychedelics and GLP-1s with Arsalan Azam, MD

In this episode of the Psychedelic Medicine Podcast, Arsalan Azam, MD joins to unpack the intersection between psychedelics and GLP-1s. Dr. Azam, founder of Daydream MD, completed his residency in Eme...

14 Juli 36min

Psilocybin vs. Ketamine with Dori Lewis, LPC

Psilocybin vs. Ketamine with Dori Lewis, LPC

In this episode of the Psychedelic Medicine Podcast, Dori Lewis, MA, MEd, LPC-S returns to discuss the differences between psilocybin and ketamine. Dori is the Clinical Director of Elemental Psychedel...

2 Juli 43min

Choosing the Right Ketamine Clinic for You with Katie Fassbinder, MD

Choosing the Right Ketamine Clinic for You with Katie Fassbinder, MD

In this episode of the Psychedelic Medicine Podcast, Katie Fassbinder, MD joins to explore how to choose the right ketamine clinic. Dr. Fassbinder is the Faculty Medical Lead for ketamine-assisted psy...

11 Juni 50min

The Future of Psychedelic Medicine with Ismail Lourido Ali, JD

The Future of Psychedelic Medicine with Ismail Lourido Ali, JD

In the 200th episode of the Psychedelic Medicine Podcast, Ismail Lourido Ali, JD joins to discuss the future of psychedelic medicine. Ismail serves as MAPS Co-Executive Director and has been actively ...

28 Maj 52min

Populärt inom Hälsa

somna-med-henrik
rss-jossan-nina
rss-bara-en-till-om-beroende-medberoende
inga-beiga-morsor
rss-vuxna-pa-latsas
bullfika
johannes-hansen-podcast
angestpodden
rss-viktmedicinpodden
sexnoveller-deluxe
sova-med-dan-horning
sa-in-i-sjalen
rss-ronden
not-fanny-anymore
tyngre-traningssnack
rss-traningsklubben
rss-basta-livet
halsoveckan-by-tyngre
rss-hos-psykologen
rss-sjalsligt-avkladd